| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 22, 2020Medtronic Foundation Commits to First-of-Its-Kind National Partnership with the Thurgood Marshall College Fund, and to Minneapolis with Support of the Northside Achievement Zone, People’s Center Clinics & Services, Among Others
MINNEAPOLIS, July 22, 2020 (GLOBE NEWSWIRE) -- The Medtronic Foundation today announced a $16 million commitment to partnerships with organizations working to bring about social justice and...
-
Apr 21, 2020Company Actively Supporting Its Employees, Customers, and Communities
DUBLIN, April 21, 2020 (GLOBE NEWSWIRE) -- Ahead of the end of its fiscal fourth quarter of fiscal year 2020, Medtronic plc (NYSE:MDT) today provided an update on its response to the COVID-19...
-
Mar 18, 2020
DUBLIN, March 18, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, continues to make progress in increasing ventilator production worldwide. The company...
-
Jan 23, 2020Efficio Software Provides Enhanced, Secure Access to Patient Data and Delivers
DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the launch of Efficio™, a cloud-based data management software for use with the SynchroMed™ II intrathecal...
-
Jan 21, 2020At Three-Months, 80% of Patients Treated with DTM SCS Reported Back Pain Relief of at Least 50%; 63% Reported Profound Back Pain Relief of 80% or Greater1
DUBLIN, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced three-month results from a large, multicenter randomized controlled trial (RCT) showing statistically significant...
-
Jan 13, 2020Full-Body MRI-Conditional InterStim II and InterStim Micro Systems Offer Lifestyle-Friendly Choices in Sacral Neuromodulation Therapy to Europeans Suffering from Incontinence
DUBLIN, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has received CE Mark for its InterStim™ Micro neurostimulator and InterStim™ SureScan™ MRI leads —...
-
Jan 8, 2020Randomized Control Trial Results to be Presented at NANS Jan. 23-26 in Las Vegas; New, Proprietary Differential Target Multiplexed (DTM) Therapy Available on Medtronic Intellis Spinal Cord Stimulation Platform
DUBLIN, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced it has acquired Stimgenics, LLC, a privately-held company based in Bloomington, Illinois, that has pioneered a novel...
-
Nov 4, 2019Action Seeks Relief to Prevent Further Infringement of Medtronic Patents
DUBLIN, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Medtronic, Inc. (NYSE:MDT) today filed a lawsuit against Axonics Modulation Technologies, Inc. (“Axonics”) alleging infringement of patents related to...
-
Aug 28, 2019Omar Ishrak Will Retire as CEO at End of Fiscal Year; Remains Chairman of the Board and Becomes Executive Chairman of Medtronic
DUBLIN, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced that Omar Ishrak, Medtronic’s Chairman and Chief Executive Officer (CEO), has announced his intention to retire...
-
Aug 16, 2019Experimental Infusion Set Aims to Address Patient Burden with Comfort and Convenience Features for Insulin Pump Therapy
DUBLIN, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it received investigational approval from the U.S. Food and Drug...